Anyone taking one of the following drugs should note a warning by the FDA of possible severe and disabling joint pain: • Sitagliptin (brand names: Januvia, Janumet, and Janumet XR) • Saxagliptin (Onglyza and Konbiglyze XR) • Linagliptin (Tradjenta, Glyxambi, and Jentadueto) • Alogliptin (Nesina, Kazano, and Oseni) Please read the article: http://www.diabeticconnect.com/diab...ral/2156-new-fda-warning-for-dpp-4-inhibitors